Biotechnology
Alterity Therapeutics Announces Expanded ATH434 Phase 2 Clinical Development Program
- Clinical trial to enroll patients with early-stage Multiple Systems Atrophy (MSA) - - Expanding bioMUSE Natural History Study - MELBOURNE, Australia and SAN FRANCISCO, Oct. 19, 2021 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology c...
2021-10-20 05:08
1496
Insilico Medicine Appoints Business Leader, Michelle Chen, as Chief Business Officer
HONG KONG and NEW YORK, Oct. 19, 2021 /PRNewswire/ -- Insilico Medicine, an end-to-end AI-powered drug discovery company, today announced the appointment of Dr.Michelle Chen to the company's position of Chief Business Officer. In this role, Dr. Chen will oversee the company's corporate strategie...
2021-10-19 23:30
2535
Excelra Announces Addition of Sudip Nandy to its Board of Directors
HYDERABAD, India, Oct. 19, 2021 /PRNewswire/ -- Excelra, a leading Data and Analytics provider for Life Science organizations, announced the appointment of Sudip Nandy to the company's board of directors effective 1st October 2021. Mr. Nandy is an acclaimed business leader with over 30 years of e...
2021-10-19 21:00
5740
Moët Hennessy Breaks New Ground For Innovation: The Robert-Jean De Vogüé Research Center
ÉPERNAY, France, Oct. 19, 2021 /PRNewswire/ -- Moët Hennessy, world leader of high-quality wine and spirits, inaugurates its new Robert-Jean de Vogüé Research Center dedicated to advancing knowledge and evolving practices. Today, climate change and biodiversity loss for more environmentally frien...
2021-10-19 21:00
2139
PharmAbcine Announces Patent Grant in Australia for Its Anti-VISTA Antibody
DAEJEON, South Korea, Oct. 19, 2021 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of next-generation antibody therapeutics, announced today that the patent for PMC-309, one of the Company's first immuno-oncology assets, has been ...
2021-10-19 20:00
1195
Harbour BioMed Announces Dosing of First Patient of Batoclimab Phase II Trial in Patients with Thyroid Eye Disease
CAMBRIDGE, Mass. and ROTTERDAM, Netherlands and SUZHOU, China, Oct. 19, 2021 /PRNewswire/ -- Harbour BioMed ("HBM", HKEX: 02142) announced that, the clinical trial of its anti-FcRn antibody, batoclimab (HBM9161), has completed the first dosing of first patient in phase II trial for the treatment ...
2021-10-19 17:52
1608
FDA Pre-Submission for Saliva-Based Glucose Test to Replace Invasive Finger-Prick
SYDNEY, Oct. 19, 2021 /PRNewswire/ -- The iQ Group Global Ltd (NSX.IQG), on behalf of its subsidiary, Life Science Biosensor Diagnostics Pty Ltd (LSBD), is pleased to announce that one of its licensees, GBS Inc (Nasdaq: GBS); a life sciences company operating in theAsia Pacific region, under lice...
2021-10-19 15:01
1527
CARB-X Funds the 3rd Round of Debiopharm's Targeted Antibiotic Program to Combat Resistant N. gonorrhoeae Infections
LAUSANNE, Switzerland and BOSTON, Oct. 19, 2021 /PRNewswire/ -- Debiopharm (
www.debiopharm.com
2021-10-19 09:00
1544
Australian businesses invited to advance the future of healthcare technologies in the Medtronic APAC Innovation Challenge
SYDNEY, Oct. 19, 2021 /PRNewswire/ -- Medtronic plc (NYSE: MDT), the global leader in healthcare technology, invites Australian businesses to participate in the newly launchedMedtronic APAC Innovation Challenge (MAIC). Providing an opportunity for innovators in the region to pitch and advance the...
2021-10-19 06:51
2784
Farmmi Healthcare Subsidiary Receives BRC and HACCP Certifications
LISHUI, China, Oct. 18, 2021 /PRNewswire/ -- Farmmi, Inc. ("Farmmi" or the "Company") (NASDAQ: FAMI) announced that one of its healthcare subsidiaries, Zhejiang Farmmi Biotechnology Co., Ltd., has been assessed and has been awarded the certificate for compliance with the requirements of BRC Glob...
2021-10-18 20:00
1452
I-Mab Announces IND Approval for Phase 2 Clinical Trial of Efineptakin Alfa in Combination with PD-1 Therapy in China
SHANGHAI and GAITHERSBURG, Md., Oct. 18, 2021 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel biologics, today announced that the Center for Drug Evaluation (CDE) of the China ...
2021-10-18 20:00
1407
WuXi ATU Opens New Manufacturing Facility to Further Enhance Its CTDMO Services for Global Customers
PHILADELPHIA, Oct. 17, 2021 /PRNewswire/ -- WuXi Advanced Therapies Inc. (WuXi ATU) – a wholly owned subsidiary of WuXi AppTec – today announced the opening of its new process development and commercial manufacturing facility in Lin-gang, Shanghai. WuXi ATU is a leading Contract, Testing, Develop...
2021-10-18 11:05
1534
Alphamab Oncology Completed Enrollment in the First Pivotal Phase III Clinical Study of the Bispecific Antibody KN046
* ENREACH-LUNG-01 is a multi-center, randomized, double-blind, placebo-controlled phase III clinical study of KN046 combined with platinum-containing chemotherapy in patients with advanced unresectable or metastatic squamous NSCLC. Enrollment of all 482 patients has been completed according to...
2021-10-18 10:19
2139
Dole Sunshine Company Partners With EDB New Ventures To Create A New Business In Specialty Ingredients Developed From Fruit Side-streams
SINGAPORE, Oct. 18, 2021 /PRNewswire/ -- Dole Sunshine Company (DSC) is partnering the Singapore Economic Development Board (EDB) for its new corporate venture, Dole Specialty Ingredients (DSI). This new venture will focus on sourcing and transforming fruit side streams and unutilised fruit parts...
2021-10-18 09:00
2169
UPL Announces Long-term Collaboration With Chr. Hansen To Develop And Commercialize Microbial Solutions For Sustainable Agriculture
- UPL is the largest manufacturer and distributor of biosolutions worldwide, fifth-largest agribusiness globally. - Chr. Hansen is the owner of one of the world's largest commercial collections of bacteria, with more than 28,000 strains - The biosolutions market set to grow to $10bn* USD by 2025...
2021-10-16 05:04
3647
Novavax to Participate in World Vaccine Congress Europe
GAITHERSBURG, Md., Oct. 16, 2021 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that Vivek Shinde, M.D., Vice President, Clinical Development, will deliver a...
2021-10-16 04:39
3953
CellOrigin secured a new round of investment for developing its globally proprietary iPSC-CAR-Macrophage technology platform
HANGZHOU, China, Oct. 15, 2021 /PRNewswire/ -- On Oct. 11th, 2021, CellOrigin Inc. released data about its second generation of iPSC-CAR-Macrophage which has a genetically integrated secondary signal to confer controlled CAR-iMac polarization, in the 5th International Conference of IGC China, 202...
2021-10-15 20:50
1299
Antengene to Present Data of Its PD-L1/4-1BB Bispecific Antibody ATG-101 and ERK1/2 Inhibitor ATG-017 at SITC 2021
SHANGHAI and HONG KONG, Oct. 15, 2021 /PRNewswire/ -- The 36th Annual Meeting of the Society for Immunotherapy for Cancer (SITC 2021) will take place in Washington, D.C., United States, on November 10-14, 2021. The SITC's annual meeting is the world's largest gathering in the field of immuno-oncol...
2021-10-15 13:33
2074
International Biopharma Industry Week Shanghai 2021 Opens
SHANGHAI, Oct. 15, 2021 /PRNewswire/ -- On October 11, the International Biopharma Industry Week Shanghai 2021, under the guidance of the Shanghai Biomedical Industry Development Leading Group, the inaugural International Biopharma Industry Week Shanghai (IBIWS) is co-hosted by Shanghai Biomedica...
2021-10-15 12:22
2369
Qiming's Portfolio Company Abbisko Lists on Main Board of HKEx
SHANGHAI, Oct. 15, 2021 /PRNewswire/ -- Qiming Venture Partners' portfolio company Abbisko (SEHK:2256), a clinical-stage biopharmaceutical company, listed on the main board of the Hong Kong Stock Exchange onOctober 13. The issue price isHK$ 12.46 per share, representing a market cap of HK$ 8.753 ...
2021-10-15 12:00
3204
Week's Top Stories
Most Reposted
Troy Animal Healthcare Strengthens Quality Operations with Veeva Vault Quality
[Picked up by 328 media titles]
2024-05-17 07:00Ultima Markets Recognised as Most Popular Broker 2024 by BrokersView
[Picked up by 321 media titles]
2024-05-15 12:00
Innomix and World Castle Association Pioneer LBMR project at Zhangbi Fortress
[Picked up by 320 media titles]
2024-05-20 13:48
Samsung Electronics Unveils Month-Long Celebration of Esports Events for Students in Southeast Asia
[Picked up by 317 media titles]
2024-05-21 08:00
Home to half of the world's top 10 trending tourism destinations, Asia Pacific is making a comeback: Mastercard Economics Institute on travel in 2024
[Picked up by 308 media titles]
2024-05-16 15:00
Most Read
Home to half of the world's top 10 trending tourism destinations, Asia Pacific is making a comeback: Mastercard Economics Institute on travel in 2024
2024-05-16 15:00
14360
Ultima Markets Recognised as Most Popular Broker 2024 by BrokersView
2024-05-15 12:00
14100
US-BASED PANDUIT ELEVATES MANUFACTURING LANDSCAPE WITH NEW STATE-OF-THE-ART PLANT IN JOHOR BAHRU, MALAYSIA
2024-05-16 09:39
12922
Troy Animal Healthcare Strengthens Quality Operations with Veeva Vault Quality
2024-05-17 07:00
12330
Casio to Release G-SHOCK-Surfrider Foundation Collaboration
2024-05-15 09:00
10993
